Defining clinical criteria for clinical remission and disease activity in collagenous colitis

Inflammatory Bowel Diseases

Volumn 15, Issue 12, 2009, Pages 1875-1881

  Hjortswang, Henrik ^a   Tysk, Curt ^b   Bohr, Johan ^b   Benoni, Cecilia ^c   Kilander, Anders ^d   Larsson, Lasse ^d   Vigren, Lina ^c   Ström, Magnus ^a  

^a LINKÖPING UNIVERSITY HOSPITAL   (Sweden)

^b ÖREBRO UNIVERSITY HOSPITAL   (Sweden)

^c LUND UNIVERSITY HOSPITAL   (Sweden)

^d SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Collagenous colitis; Disease activity; Health; Health related quality of life; IBD; Inflammatory bowel disease; Microscopic colitis; Quality of life; Remission

Indexed keywords

ABDOMINAL PAIN; ADULT; AGED; ARTICLE; CLINICAL FEATURE; COHORT ANALYSIS; COLLAGENOUS COLITIS; COLON BIOPSY; CROSS-SECTIONAL STUDY; DEFECATION HABIT; DEFECATION URGENCY; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HEALTH SURVEY; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOMES RESEARCH; PRIORITY JOURNAL; PSYCHOLOGICAL ASPECT; QUALITY OF LIFE; QUESTIONNAIRE; REMISSION; SYMPTOMATOLOGY; WELLBEING;

AGED; COLITIS, COLLAGENOUS; CROSS-SECTIONAL STUDIES; FECES; FEMALE; HUMANS; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); QUALITY OF LIFE; REMISSION INDUCTION; SEVERITY OF ILLNESS INDEX;

EID: 72549086962     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.20977     Document Type: Article

References (23)

1. Nyhlin N, Bohr J, Eriksson S, et al. Systematic review: microscopic colitis. Aliment Pharmacol Ther. 2006;23:1525-1534.
2. Bohr J, Tysk C, Eriksson S, et al. Collagenous colitis: a retrospective study of clinical presentation and treatment in 163 patients. Gut. 1996;39:846-851. (Pubitemid 27049088)
3. Jessurun J, Yardley JH, Giardiello FM, et al. Chronic colitis with thickening of the subepithelial collagen layer (collagenous colitis): histopathological findings in 15 patients. Hum Pathol. 1987;18;839-848. (Pubitemid 18049857)
4. Olesen M, Eriksson S, Bohr J, et al. Microscopic colitis: a common diarrheal disease. An epidemiological study in Örebro, Sweden, 1993-1998. Gut. 2004;53:346-350.
5. Madisch A, Heymer P, Voss C, et al. Oral budesonide therapy improves quality of life in patients with collagenous colitis. Int J Colorect Dis. 2005;20:312-316. (Pubitemid 40909227)
6. Miehlke S, Heymer, Bethke B, et al. Budesonide treatment for collagenous colitis: a randomized double-blind, placebo-controlled, multicenter trial. Gastroenterology. 2002;123:978-984.
7. Baert F, Schmit A, D'Haens G, et al. Budesonide in collagenous colitis: a double blind placebo-controlled trial with histologic follow-up. Gastroenterology. 2002;122:20-25. (Pubitemid 34049190)
8. Bonderup OK, Hansen JB, Birket-Smith L, et al. Budesonide treatment of collagenous colitis: a randomised, double-blind, placebo controlled trial with morphometric analysis. Gut. 2003;52:248-251. (Pubitemid 36115067)
9. Munck LK, Kjeldsen J, Philipsen E, et al. Incomplete remission with short-term prednisolone treatment in collagenous colitis: a randomized study. Scand J Gastroenterol. 2003;38:606-610. (Pubitemid 36724039)
10. Miehlke S, Madisch A, Voss C, et al. Long-term follow-up of collagenous colitis after induction of clinical remission with budesonide. Aliment Pharmacol Ther. 2005;22:1115-1119. (Pubitemid 41779519)
11. Miehlke S, Madisch A, Bethke B, et al. Oral budesonide for maintenance treatment of collagenous colitis: a randomized, double-blind, placebo-controlled trial. Gastroenterology. 2008;135:1510-1516.
12. Bonderup OK, Hansen JB, Teglbjaerg PS, et al. Long-term budesonide treatment of collagenous colitis: a randomised, double-blind, placebo controlled trial. Gut. 2009;58:68-72.
13. Goff JS, Barnett JL, Pelke T, et al. Collagenous colitis: histopathology and clinical course. Am J Gastroenterol. 1997;92:57-60. (Pubitemid 27027029)
14. Hjortswang H, Järnerot G, Curman B, et al. The Short Health Scale: a valid measure of subjective health in ulcerative colitis. Scand J Gastroenterol. 2006;41:1196-1203. (Pubitemid 44451683)
15. Stjernman H, Grännö C, Järnerot G, et al. Short Health Scale: a valid, reliable, and responsive instrument for subjective health assessment in Crohn's disease. Inflamm Bowel Dis. 2008;14:47-52. (Pubitemid 351196868)
16. Dupuy HJ. The psychological general well-being (PGWB) index. In: Wenger NK, Mattson ME, Furberg CF, Elinson J. Assessment of Quality of Life in Clinical Trials of Cardiovascular Therapies. Hoboken, NJ: Le Jacq Publishing; 1984:170-183.
17. Irvine EJ, Feagan B, Rochon J, et al. Quality of life: a valid and reliable measure of the therapeutic efficacy in the treatment of inflammatory bowel disease. Gastroenterology. 1994;106:287-296. (Pubitemid 24041204)
18. Drossman DA, Leserman J, Li Z, et al. The Rating Form of IBD Patient Concerns: a new measure of health status. Psychosom Med. 1991;53:701-712.
19. Wiklund I, Karlberg J. Evaluation of quality of life in clinical trials: selecting quality of life measures. Controlled Clin Trials. 1991;12:S204-216.
20. Hjortswang H, Järnerot G, Curman B, et al. Validation of the inflammatory bowel disease questionnaire (IBDQ) in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 2001;36:77-85. (Pubitemid 32147185)
21. Stjernman H, Grännö C, Bodemar G, et al. Evaluation of the inflammatory bowel disease questionnaire in Swedish patients with Crohn's disease. Scand J Gastroenterol. 2006;41:934-943. (Pubitemid 43995469)
22. Hjortswang H, Ström M, Almeida RT, et al. Evaluation of the RFIPC, a disease-specific health-related quality of life questionnaire, in Swedish patients with ulcerative colitis. Scand J Gastroenterol. 1997;32:1235-1240. (Pubitemid 28023128)
23. Walter SA, Skagerström E, Bodemar G. Subgroups of irritable bowel syndrome: a new approach. Eur J Gastroenterol Hepatol. 2004;16:991-994. (Pubitemid 39411116)